1. Abbott Laboratories (2007) ABT-711 M02-547 clinical study report. Available at
http://www.clinicalstudyresults.org
/documents/company-study_782_0.pdf. Accessed March 19, 2007
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text revision. American Psychiatric Association, Washington, DC
3. Andrezina R, Josiassen RC, Marcus RN et al (2006a) Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berl) 188:281–292
4. Andrezina R, Marcus RN, Oren DA et al (2006b) Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Curr Med Res Opin 22:2209–2219
5. Arango C, Bernardo M (2005) The effect of quetiapine on aggression and hostility in patients with schizophrenia. Hum Psychopharmacol 20:237–241